|
|
||||||||
1 Departments of Entomology and Forestry and Horticulture, The Connecticut Agricultural Experiment Station, P.O. Box 1106, New Haven, Connecticut 06504, USA
2 Section of Rheumatology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520, USA
3 Community Services Associates, Inc., 175 Greenwood Drive, Hilton Head Island, South Carolina 29928, USA
5 Corresponding author (email: louis.magnarelli{at}po.state.ct.us)
| ABSTRACT |
|---|
|
|
|---|
Key words: Anaplasma phagocytophilum, antibodies, Borrelia burgdorferi, ELISA, Odocoileus virginianus.
| INTRODUCTION |
|---|
|
|
|---|
A variety of serologic tests, such as indirect fluorescent antibody (IFA) staining methods, Western blot analysis, and enzyme-linked immunosorbent assays (ELISAs), have been used to verify past or current infections of B. burgdorferi and A. phagocytophilum infections (Lane et al., 1994; Luttrell et al., 1994; Magnarelli et al., 1999; Arens et al., 2003). Although sensitivities and specificities of these assays were considered acceptable, there is potential for false positive reactions when whole-cell antigens are used because heat-shock, flagellin, or other proteins of these pathogens may be shared with other bacteria. Recent advances in the production and use of purified recombinant antigens (i.e., fusion proteins) in ELISAs to detect antibodies in human, dog, horse, and bovine sera (IJdo et al., 1999; Magnarelli et al., 2001a, b, c, 2002a, Magnarelli et al., b) have improved laboratory analyses. The objectives of the present study were to develop and evaluate ELISAs incorporating highly specific recombinant antigens of A. phagocytophilum and B. burgdorferi, to compare assay performance, and to calculate seropositivity rates for infections in deer from the northeastern and the southeastern United States.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Seventeen to 35 negative control sera, tested before by IFA or ELISA methods with whole-cell antigens (Magnarelli et al., 1995, 1999), were used to calculate net absorbance values to define critical regions for positive results. Net absorbance values represent differences in optical density (OD) readings for reactions with or without antigen for each serum dilution. Statistical analyses (three standard deviations plus the mean) of net OD values were used to determine cutoff figures for a positive reaction. In an ELISA with the p44 antigen, net OD values of 0.10 and 0.06 were considered positive for serum dilutions of 1:160 and
1:320. In an ELISA incorporating B. burgdorferi recombinant OspE, critical regions of 0.13, 0.08, and 0.04 defined positive results, whereas a cutoff value of 0.04 was established for all serum dilutions for OspC, p35, and p41-G. Cutoff regions for OspF and p39 antigens were, respectively, 0.07, 0.04, and 0.04 and 0.15, 0.15, and 0.09 for serum dilutions of 1:160, 1:320, and
1:640. Cutoff values for tests with VlsE antigen were 0.07 and 0.03.
Specificity studies were continued as an extension of previous work (Magnarelli et al., 1986, 1999) to assess potential for false positive reactions in an ELISA incorporating new lots of recombinant antigens. Six broadly reactive positive control deer sera, two containing homologous antibodies to A. phagocytophilum and four homologous antibody-positive samples from animals inoculated with B. burgdorferi; plus six cattle sera with homologous antibodies to Anaplasma marginale; and one cow serum positive for Brucella antibodies were tested with the full panel of antigens. Positive cattle sera were included in these tests because these animals are closely related to deer. Companion blood samples for the two deer sera with antibodies to A. phagocytophilum were shown earlier (Magnarelli et al., 1999) to have DNA of this agent. Also, cattle with A. marginale antibodies were known to have red blood cells infected with this pathogen. In all analyses of cattle sera, peroxidase-labeled goat anti-bovine antibodies (Kirkegaard and Perry Laboratories) were diluted in PBSS to 1:8,000.
Western blot and PCR analyses were conducted to assess ELISA results for A. phagocytophilum antibodies. Matching whole blood and serum samples, obtained from 39 deer during 1996 in Connecticut, were used to determine concordance of results. Details on the preparation and use of lysates of infected and uninfected HL-60 cells and on other materials and procedures for immunoblotting have been described (Magnarelli et al., 1999). Similarly, methods used to prepare genomic DNA for PCR analyses and procedures applied to detect the DNA of A. phagocytophilum in whole-blood samples have been reported (Magnarelli et al., 1999).
A z-test was used to determine significant differences in percentages of positive results. Analysis included the Yates correction as a part of the statistical software program (SigmaStat, SPSS Inc., Chicago, Illinois, USA).
| RESULTS |
|---|
|
|
|---|
Serologic test results for 20 deer sera from South Carolina revealed comparatively fewer seropositives. Reactivity to recombinant p41G was most frequent (n=11 positives); antibody concentrations varied (1:160 to 1:1,280). The highest antibody titer (1:1,280) was recorded for two sera reactive to VlsE antigen. Six sera (30%) contained antibodies to whole-cell B. burgdorferi. Of these, five sera also had antibodies to recombinant p41G (n=5), VlsE (n=1), OspC (n=1), or OspF (n=1). Similarly, there were six seropositives for A. phagocytophilum whole-cell antibodies by IFA staining methods (titers=1:160 to 1:640), five of which also reacted to the p44 antigen by ELISA (titers=1:640 to 1: 1:2,560). Three deer sera contained antibodies to B. burgdorferi and A. phagocytophilum.
Seropositivity rates for an ELISA with VlsE antigen were highly concordant with those determined by an ELISA with whole-cell B. burgdorferi antigens. Of the 218 Connecticut sera screened by both assays, 92 and 90 sera were positive and negative, respectively, in both assays (84% agreement). Results for the remaining 36 sera differed; 23 samples were positive to whole-cell antigen and negative to VlsE, while the reverse was noted for 13 sera.
Antibody test results for A. phagocytophilum revealed a concordance of 71% when findings for an ELISA incorporating the p44 antigen were compared with those of IFA staining methods with whole-cell antigens. Seventy-six sera were positive in both tests, while 88 samples were negative. Thirty-seven other sera reacted to the p44 antigen by an ELISA but were negative by IFA methods. The remaining 17 sera were positive by IFA and negative by an ELISA.
Concentrations of antibodies varied. In analyses for B. burgdorferi immunoglobulins, antibody titers generally ranged between 1:160 and 1:5,120 (Table 2
). Maximal titration endpoints and an elevated geometric mean (698) were recorded when VlsE antigen was incorporated into an ELISA. Two sera had antibody titers of 1:10,240 to this antigen. Similar results were obtained when the p44 recombinant antigen was used in an ELISA. Five sera had antibody titers of 1:10,240, while one serum sample had an endpoint of 1: 40,980.
|
|
Minor cross-reactivity occurred when cattle sera containing antibodies to A. marginale or Brucella were tested with whole-cell or recombinant antigens of B. burgdorferi or A. phagocytophilum. One serum with A. marginale antibodies was positive to p41G and VlsE antigens at titers of 1: 160 and 1:320, respectively, while another sample in this group reacted with p44 (titer=1:640) antigen. The serum sample with Brucella antibodies reacted to whole-cell B. burgdorferi in an ELISA at a titer of 1:320. The remaining four cattle sera and the positive control deer sera were negative to all heterologous antigens included in this study.
| DISCUSSION |
|---|
|
|
|---|
Although antibodies were produced to whole cells and to one or more recombinant antigens of B. burgdorferi, seropositivity to VlsE greatly exceeded serum reactivities to all other fusion proteins of this pathogen and was comparable to overall results for an ELISA with whole cells. There were several positives for OspF antibodies but at much lower frequency. A similar pattern of reactivity was noted when human sera from patients who had erythema migrans were tested for class-specific antibodies (Magnarelli et al., 2002b). The VlsE antigen was judged to be the most suitable test antigen for diagnosis of early infections because of its high sensitivity and specificity. Other investigators have demonstrated utility of this antigen, regardless of whether a full-length recombinant VlsE (Lawrenz et al., 1999; Bacon et al., 2003; Schulte-Spechtel et al., 2003) or a peptide corresponding to the invariant IR6 region of the VlsE antigen (Liang et al., 2001; Bacon et al., 2003) was used in an ELISA. The VlsE antigen evaluated in the present study is a desirable test antigen for confirming past or current B. burgdorferi infections in deer. Information on serum reactivity to OspF is also useful for confirmatory purposes.
The variable findings for antibody-positive deer sera at different sites in Connecticut parallel those reported for horses there (Magnarelli et al., 2000b) and for deer elsewhere (Gallivan et al., 1998). It is clear that there are numerous foci for both pathogens in Connecticut, where I. scapularis ticks are abundant. There also is evidence of these infectious agents in deer and horses in the southeastern United States (Mahnke et al., 1993; Magnarelli et al., 2001c), but seroprevalence appears to be much lower there. Regional and local differences in seropositivity values for B. burgdorferi are probably due, in part, to variable sample sizes, numbers of infected ticks feeding on hosts, variations in host immune responses among subjects to the same or different strains of the spirochete (Lane et al., 1994; Luttrell et al., 1994), and the timing of antibody responses relative to sampling (Gallivan et al., 1998). In experimentally challenged deer, antibody responses to B. burgdorferi occurred rapidly after inoculation (Luttrell et al., 1994) and peaked 6 to 7 wk later. However, it is unknown how long these immunoglobulins persist over several months. There is less information on humoral responses to A. phagocytophilum and persistence of antibodies in deer. Therefore, interpretation of seropositivity rates is difficult. High prevalences of seropositive specimens may not necessarily correlate with prevalence of infected ticks at selected sites.
In analyses for antibodies to A. phagocytophilum, seroprevalence for the p44 recombinant antigen in an ELISA exceeded that for whole-cell antigens determined by IFA staining methods. Earlier studies demonstrated the value of this antigen in analyses of human and horse sera (IJdo et al., 1999; Magnarelli et al., 2001c) where Western blot analyses confirmed ELISA results. In the present study, there was relatively high concordance when results of immunoblotting and ELISA were compared. Detection of A. phagocytophilum DNA for some samples supports evidence of infection. Therefore, reactivity of deer sera to the p44 antigen appears to be an important indicator of exposure to A. phagocytophilum.
A lower concordance value was noted when antibody test results for A. phagocytophilum were compared with PCR findings. In earlier studies of deer (Belongia et al., 1997; Arens et al., 2003), which focused on B. burgdorferi, Ehrlichia chaffeensis, or Ehrlichia ewingii, and of horses with A. phagocytophilum infections (Van Andel et al., 1998; Magnarelli et al., 2001c), investigators found that DNA findings sometimes do not correlate well with antibody test results. Pathogens may be present in blood for relatively short periods (i.e., a few weeks) following initial infection via tick bites. During early infection, antibody concentrations are usually too low to be detected by an ELISA, regardless of the antigen used. With time and an ensuing expansion in humoral responses, antibody concentrations rise and, therefore, along with mounting cell-mediated immune responses, may be sufficient to depress pathogen concentrations. For laboratory diagnosis of equine granulocytic ehrlichiosis, it was concluded that DNA analyses were most suitable during the early days of acute infection, while antibody tests were more practical several days later when horses were convalescing (Van Andel et al., 1998; Magnarelli et al., 2001c). Therefore, different methods should be used to confirm A. phagocytophilum infections. In the present study, it is unknown when deer were infected with this agent, but, as observed for horse infections (Van Andel et al., 1998), it is possible that the positive DNA results were indicating recent infections associated with the bites of I. scapularis females during the fall.
Results of specificity testing indicated minor cross-reactivity when cattle sera with A. marginale or Brucella antibodies were screened against B. burgdorferi and A. phagocytophilum antigens. In general, heterologous antibody titers were relatively low, and the false positives were probably a result of normal assay variability. In tests of reproducibility, up to fourfold variation of antibody titers was recorded. In earlier studies (Magnarelli et al., 1986), low-titered reactions (1:64 to 1:128) were noted when deer sera containing antibodies to B. burgdorferi were screened by IFA staining methods against Leptospira interrogans serovars (pomona, hardjo, and icterohemorrhagiae) and Treponema denticola. In southern states where lone star ticks (Amblyomma americanum) are abundant, Borrelia lonestari may geographically coexist with B. burgdorferi in some areas. Serologic cross-reactivity in antibody tests is possible because many antigens are shared among Borrelia species. Therefore, caution should be used when interpreting low-titered reactions. Also, it is important to know the geographic distributions and host records for pathogens; B. lonestari and A. marginale are not known to occur in the northeastern United States. Although predominantly a pathogen of cattle, the latter has been reported infecting deer and elk (Cervus elaphus) in other regions of the United States (Keel et al., 1995; Zaugg et al., 1996).
An ELISA with recombinant VlsE or p44 antigens is suitable for testing deer sera for antibodies to B. burgdorferi and A. phagocytophilum in the eastern United States. However, depending on genotypic differences of the pathogen strains present in widely separated regions and immune responses of hosts, key outer surface proteins (relied on as markers in laboratory tests) may be variably expressed or differentially recognized immunologically. Studies are needed to determine whether both antigens are acceptable for analyses of deer sera in the western United States or Europe where related Ixodes ticks occur. Previous work has demonstrated that a synthetic peptide based on the VlsE IR6 of Borrelia garinii (strain Ip90) has an epitope that frequently reacts with human serum antibodies produced in Lyme borreliosis infections in the United States and Europe (Liang et al., 1999, 2000, 2001), but consistency of results sometimes varied. Nonetheless, in heavily tick infested areas of the northeastern United States, an ELISA with VlsE or p44 antigens can be used as an adjunct procedure along with assays containing whole-cell antigens for general screening purposes to determine whether deer are exposed to B. burgdorferi and A. phagocytophilum, while PCR analyses can be relied on to provide more direct evidence of infection.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| LITERATURE CITED |
|---|
|
|
|---|
ARENS, M. Q., A. M. LIDDELL, G. BUENING, M. GAUDREAULT-KEENER, J. W. SUMNER, J. A. COMER, R. S. BULLER, AND G. A. STORCH. 2003. Detection of Ehrlichia spp. in the blood of wild white-tailed deer in Missouri by PCR assay and serologic analysis. Journal of Clinical Microbiology 41: 12631265.
BACON, R. M., B. J. BIGGERSTAFF, M. E. SCHRIEFER, R. D. GILMORE JR., M. T. PHILIPP, A. C. STEERE, G. P. WORMSER, A. R. MARQUES, AND B. J. B. JOHNSON. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with the 2-tiered testing using whole-cell lysates. Journal of Infectious Diseases 187: 11871199.[Medline]
BELONGIA, E. A., K. D. REED, P. D. MITCHELL, C. P. KOLBERT, D. H. PERSING, J. S. GILL, AND J. J. KAZMIERCZAK. 1997. Prevalence of granulocytic Ehrlichia infection among white-tailed deer in Wisconsin. Journal of Clinical Microbiology 35: 14651468.[Abstract]
DUMLER, J. S., A. F. BARBET, C. P. J. BEKKER, G. A. DASCH, G. H. PALMER, S. C. RAY, Y. RIKIHISA, AND F. R. RURANGIRWA. 2001. Reorganization of the genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: Unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia, and Ehrlichia with Neorickettsia, descriptions of six new species combinations and designation of Ehrlichia equi and HGE agent as subjective synonyms of Ehrlichia phagocytophila. International Journal of Systematic and Evolutionary Microbiology 51: 21452165.[Abstract]
GALLIVAN, G. J., I. K. BARKER, H. ARTSOB, L. A. MAGNARELLI, J. T. ROBINSON, AND D. VOIGT. 1998. Serologic survey for antibodies to Borrelia burgdorferi in white-tailed deer in Ontario. Journal of Wildlife Diseases 34: 411414.[Abstract]
IJDO, J. W., C. WU, L. A. MAGNARELLI, AND E. FIKRIG. 1999. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 37: 35403544.
KEEL, M. K., W. L. GOFF, AND W. R. DAVIDSON. 1995. An assessment of the role of white-tailed deer in the epizootiology of anaplasmosis in the southeastern United States. Journal of Wildlife Diseases. 31: 378385.[Abstract]
LANE, R. S., D. P. BERGER, L. E. CASHER, AND W. BURGDORFER. 1994. Experimental infection of Columbian black-tailed deer with the Lyme disease spirochete. Journal of Wildlife Diseases 30: 2028.[Abstract]
LAWRENZ, M. B., J. M. HARDHAM, R. T. OWENS, J. NOWAKOWSKI, A. C. STEERE, G. P. WORMSER, AND S. J. NORRIS. 1999. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. Journal of Clinical Microbiology 37: 39974004.
LIANG, F. T., A. C. STEERE, A. R. MARQUES, B. J. B. JOHNSON, J. N. MILLER, AND M. T. PHILIPP. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. Journal of Clinical Microbiology 37: 39903996.
, E. ABERER, M. CINCO, L. GERN, C. M. HU, Y. N. LOBET, M. RUSCIO, P. E. VOET JR., V. E. WEYNANTS, AND M. T. PHILIPP. 2000. Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. Journal of Infectious Diseases 182: 14551462.[Medline]
, L. BOWERS, AND M. T. PHILIPP. 2001. C-terminal invariable domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes. Infection and Immunity 69: 32243231.
LITTLE, S. E., D. E. STALLKNECHT, J. M. LOCKHART, J. E. DAWSON, AND W. R. DAVIDSON. 1998. Natural coinfection of a white-tailed deer population with three Ehrlichia spp. Journal of Parasitology 84: 897901.[Medline]
LUTTRELL, M. P., K. NAKAGAKI, E. W. HOWERTH, D. E. STALLKNECHT, AND K. A. LEE. 1994. Experimental infection of Borrelia burgdorferi in white-tailed deer. Journal of Wildlife Diseases 30: 146154.[Abstract]
MAGNARELLI, L. A., J. F. ANDERSON, C. S. APPERSON, D. FISH, R. C. JOHNSON, AND W. A. CHAP-PELL. 1986. Spirochetes in ticks and antibodies to Borrelia burgdorferi in white-tailed deer from Connecticut, New York State, and North Caro-lina. Journal of Wildlife Diseases 22: 178188.[Abstract]
, A. DENICOLA, K. C. STAFFORD III, AND J. F. ANDERSON. 1995. Borrelia burgdorferi in an urban environment: White-tailed deer with infected ticks and antibodies. Journal of Clinical Microbiology 33: 541544.[Abstract]
, J. W. IJDO, J. F. ANDERSON, S. J. PADULA, R. A. FLAVELL, AND E. FIKRIG. 1998. Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut. Journal of Clinical Microbiology 36: 28232827.
, , K. C. STAFFORD III, AND E. FIKRIG. 1999. Infections of granulocytic ehrlichiae and Borrelia burgdorferi in white-tailed deer in Con-necticut. Journal of Wildlife Diseases 35: 266274.[Abstract]
, , S. J. PADULA, R. A. FLAVELL, AND E. FIKRIG. 2000a. Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosor-bent assays with recombinant antigens. Journal of Clinical Microbiology 38: 17351739.
, , A. E. VAN ANDEL, C. WU, S. J. PAD-ULA, AND E. FIKRIG. 2000b. Serologic confir-mation of Ehrlichia equi and Borrelia burgdor-feri infections in horses from the northeastern United States. Journal of the American Veterinary Medical Association 217: 10451050.[Medline]
, , C. WU, AND E. FIKRIG. 2001a. Recombinant protein-44-based class-specific enzyme-linked immunosorbent assays for serologic diagnosis of human granulocytic ehrlichiosis. European Journal of Clinical Microbiology and Infectious Diseases 20: 482485.[Medline]
, S. A. LEVY, J. W. IJDO, C. WU, S. J. PADULA, AND E. FIKRIG. 2001b. Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis. Journal of Medical Microbiology 50: 889895.
, J. W. IJDO, A. E. VAN ANDEL, C. WU, J. H. OLIVER JR., AND E. FIKRIG. 2001c. Reactivity of serum samples of dogs and horses tested by use of class-specific recombinant-based enzyme-linked immunosorbent assays for detection of granulocytic ehrlichiosis. American Journal of Veterinary Research 9: 13651369.
, , B. A. SHERMAN, S. L. BUSHMICH, S. A. LEVY, AND E. FIKRIG. 2002a. Antibodies to granulocytic ehrlichiae in cattle from Con-necticut. Journal of Medical Microbiology 51: 326331.
, M. LAWRENZ, S. J. NORRIS, AND E. FIKRIG. 2002b. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immu-nosorbent assays for Lyme borreliosis. Journal of Medical Microbiology 51: 649655.
MAHNKE, G., D. E. STALLKNECHT, C. E. GREENE, V. F. NETTLES, AND M. A. MARKS. 1993. Serologic survey for antibodies to Borrelia burgdor-feri in white-tailed deer in Georgia. Journal of Wildlife Diseases 29: 230236.[Abstract]
SCHULTE-SPECHTEL, U., G. LEHNERT, G. LIEGL, V. FINGERLE, C. HEIMERL, B. J. B. JOHNSON, AND B. WILSKE. 2003. Significant improvement of the recombinant Borrelia-specific immunoglob-ulin G immunoblot test by addition of VlsE and DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. Journal of Clinical Microbiology 41: 12991303.
THOMAS, V., J. ANGUITA, S. W. BARTHOLD, AND E. FIKRIG. 2001. Coinfection with Borrelia burg-dorferi and the agent of human granulocytic ehr-lichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infection and Immunity 69: 33593371.
VAN ANDEL, A. E., L. A. MAGNARELLI, R. HEIMER, AND M. WILSON. 1998. Development and duration of antibody response against Ehrlichia equi in horses. Journal of the American Veterinary Medical Association 212: 19101914.[Medline]
WALKER, D. H. AND J. S. DUMLER. 1996. Emergence of the ehrlichioses as human health problems. Emerging Infectious Diseases 2: 1829.[Medline]
, A. G. BARBOUR, J. H. OLIVER, R. S. LANE, J. S. DUMLER, D. T. DENNIS, D. H. PERSING, A. F. AZAD, AND E. MCSWEEGAN. 1996. Emerging bacterial zoonotic and vector-borne diseases: Ecological and epidemiological factors. Journal of the American Medical Association 275: 463469.[Abstract]
ZAUGG, J. L., W. L. GOFF, W. FOREYT, AND D. L. HUNTER. 1996. Susceptibility of elk (Cervus elaphus) to experimental infection with Anaplasma marginale and A. ovis. Journal of Wildlife Diseases 32: 6266.[Abstract]
Received for publication 14 July 2003.
This article has been cited by other articles:
![]() |
L. A. Magnarelli, K. C. Stafford III, J. W. IJdo, and E. Fikrig ANTIBODIES TO WHOLE-CELL OR RECOMBINANT ANTIGENS OF BORRELIA BURGDORFERI, ANAPLASMA PHAGOCYTOPHILUM, AND BABESIA MICROTI IN WHITE-FOOTED MICE J. Wildl. Dis., October 1, 2006; 42(4): 732 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tate, D. G. Mead, M. P. Luttrell, E. W. Howerth, V. G. Dugan, U. G. Munderloh, and W. R. Davidson Experimental Infection of White-Tailed Deer with Anaplasma phagocytophilum, Etiologic Agent of Human Granulocytic Anaplasmosis J. Clin. Microbiol., August 1, 2005; 43(8): 3595 - 3601. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |